Further studies have shown that TGFβ/Smad pathway can be activated by platelet-secreted TGFβ1 and NF-κB pathway can be triggered by direct contact between tumor cells and platelets, and the latter can enhance the TGFβ1 transcriptional response of tumor cells. Here, TGFB1 is linked to neoplasm.